222 results
Hydromorphone use for acute pain: Misconceptions, controversies, and risks. Motov et al
https://www.ncbi.nlm.nih.gov/pubmed/29508897

Visual Abstract by David Cisewski,
use for acute pain ... pubmed/29508897 Visual ... Abstract by David ... Overview #Safety #Pharmacology ... VisualAbstract #Pain
Association of an Opioid Standard of Practice Intervention With Intravenous Opioid Exposure in Hospitalized Patients

Source Article:
fullarticle/2681060 Visual ... Abstract by David ... #Intravenous #Pain
The AIRWAYS-2 Randomized Clinical Trial Infographic - A Visual Abstract

Effect of a Strategy of a Supraglottic
AIRWAYS-2 Randomized Clinical ... Infographic - A Visual ... Abstract Effect ... journals/jama/article-abstract
Hospitalization for the Evaluation of Patients with Low Risk Chest Pain 
Choosing Wisely: Things We Do
Low Risk Chest Pain ... things-we-do-no-reason-hospitalization-evaluation-patients Visual ... Abstract by Dr.
SALT-ED Trial - Balanced Crystalloids versus Saline in Noncritically Ill Adults

N Engl J Med 2018; 378:819-828
hospital-free days between treatment ... crystalloids and treatment ... - Visual Abstract
POLAR Randomized Clinical Trial - Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients
POLAR Randomized Clinical ... journals/jama/article-abstract ... - Visual Abstract
Polyarteritis Nodosa (PAN): Pathogenesis and Clinical Findings

Medical Comorbidities Malignancies (most commonly hairy-cell leukemia)
Immunogenetic Predisposition: patient is
Polyarteritis Nodosa (PAN ... Pathogenesis and Clinical ... Postulate 1 - Viral ... Orchitis: Testicular pain ... Non-specific abdo pain
TOPCAT - Spironolactone for Heart Failure with Preserved Ejection Fraction

N Engl J Med 2014; 370:1383-1392 https://www.nejm.org/doi/10.1056/NEJMoa1313731

CONCLUSIONS:
ejection fraction, treatment ... - Visual Abstract
Elagolix (Orilissa) - Pharmacology Review
Elagolix is a small-molecule GnRH antagonist recently approved by the FDA for
Elagolix (Orilissa) - Pharmacology ... the FDA for the treatment ... moderate-severe pain ... #Pharmacology #Elagolix
Neuromodulators for Disorders of Gut Brain Interactions (DGBIs)
SSRIs - When anxiety, depression, and phobic features are
TCAs - First-line treatment ... when pain is dominant ... sleep SNRls - Treatment ... when pain in dominant ... Neuromodulators #DGBIs #IBS #pharmacology